Navigation Links
Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
Date:4/10/2008

els of the Bicyclolides. The convenience of oral administration and the safety profile of macrolides as a class represent patient and pharmacoeconomic benefits that could be potentially quite significant, making this program a worthwhile endeavor."

About Enanta's Bicyclolide research program

Bicyclolides posses a reengineered back-bone structure of traditional macrolides, whose benefits include the potential for oral and intravenous administration and limited side-effects. The discovery of Bicyclolides' effectiveness against MRSA and VRE infections is part of Enanta's broad antibiotic research program. Enanta has applied several research strategies to develop these new classes of antibiotics, including innovative medicinal chemistry approaches to create novel and proprietary chemical structures. Enanta has applied its chemistry approach to create promising product pipelines and a vast intellectual property estate.

About MRSA

More than 130,000 people each year need hospital care for MRSA, according to the Centers for Disease Control and Prevention. Staphylococcus aureus is a bacterium that can live harmlessly on human skin and is found in the nose of 20 to 40 percent of healthy individuals, but can sometimes cause infections when exposed to broken skin. MRSA is a particular type of the bacteria that has developed resistance to many antibiotics, including methicillin, making it difficult to treat. Currently, the antibiotic drugs typically administered to MRSA patients are intravenous. This method is expensive and inconvenient, especially for those who acquired the infection in the community and must seek hospital treatment for lengthy intravenous treatment.

About Enanta

Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best in class small molecule drugs in the anti-infective field. At the heart of Enanta is its commitment to innovative
'/>"/>

SOURCE Enanta Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
3. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
4. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
5. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
8. NPS Reports Successful GATTEX(TM) Extension Study
9. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
10. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
11. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Sarnova, parent company ... of the new www.tri-anim.com website, continuing ... healthcare distributor of respiratory, anesthesia and other critical ... The site has many new features ... making online shopping and ordering easier and more ...
(Date:3/2/2015)... , March 2, 2015  Tandem Diabetes Care®, Inc. ... and manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... public offering of common stock have exercised their option ... stock at a price to the public of $11.50 ... offering is expected to be $64.8 million, after deducting ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 Aurora Fit ... celebration and charity drive to observe the opening of the ... charity organization Ashleigh’s Hope. The event will be held on ... S #7, Aurora, ON. The opening will feature free boot ... Fit Body Boot Camp is the world’s most popular and ...
(Date:3/2/2015)... Formetco today announced the official launch ... FTX uses state-of-the-art technology to deliver an outdoor advertising ... satisfaction. An item of particular value, and previously ... year LED Brightness Warranty. , Why the FTX was ... billboard among any other billboard product in the world. ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Dr. David ... injury, is partnering with Doctors on Liens ... patients. It’s rare for personal injury victims to ... and especially on a lien basis. However, San ... outstanding team of chiropractors, M.D., pain management physician, massage, ...
(Date:3/2/2015)... New York, NY (PRWEB) March 02, 2015 ... a long history of catalyzing private sector activities ... that it has recently elected four new members ... , GBCHealth welcomes Dr. Paul Farmer, Chief Strategist ... University Professor at Harvard University; Dr. Huma Abbasi, ...
(Date:3/2/2015)... 02, 2015 “ Wants and Needs ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this app helps people evaluate priorities. , Whether a ... Wants and Needs app. The app allows people to ...
Breaking Medicine News(10 mins):Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 2Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 3Health News:Formetco Launches Innovative LED Billboard System 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2
... Recent researcher has shown that there is no link ... over the past few years has suggested vaccinations that ... polio, diphtheria and other diseases might be putting children ... ,Studies have shown countries where childhood vaccinations are ...
... coronavirus. Similar viruses infect the pigs and other animals. It ... more than two dozen countries on four continents before it ... were sickened, and at least 774 died.Civet cats and other ... southern China are suspected of spreading SARS to humans although ...
... exercising and the prevention and survival rates of certain ... results from nearly 850 women with endometrial cancer, aged ... of exercise activity during their adolescent and adult years.Results ... life were up to 40 percent less likely to ...
... Latest researcher show that a few alcoholic beverages a ... disease in men // with high blood pressure. ... had a significantly lower risk of death by nearly ... a reduced risk of cardiovascular disease death as alcohol ...
... cancer patients by 63 percent with their latest drug ... trial strengthens the case for administering the newer drug, ... women recovering from breast cancer lowered their chance of ... to exemestane after two or three years of tamoxifen ...
... Sports and Exercise and the Center for Asthma and Allergy Care, ... 18-year olds who had at least one risk factor for asthma. ... risk factor noted by children was a family member having allergies ... 10 minutes. Forced expiratory volume ( FEV ) was measured at ...
Cached Medicine News:Health News:SARS vaccine shows promise in Animal Testing 2
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... test kit is a solid phase enzyme ... is designed for the quantitative measurement of ... serum or plasma. The microplate is coated ... and patient samples are pipetted into the ...
Free T3 EIA Thyroid Function 025-BC-1006...
Prolactin EIA Reproductive Markers 025-BC-1037...
Medicine Products: